11C-PiB PET imaging of encephalopathy associated with cerebral amyloid angiopathy

Internal Medicine

Volumn 53, Issue 17, 2014, Pages 1997-2000

  Sengoku, Renpei ^a,b   Matsushima, Satoshi ^a   Murakami, Yoshitake ^c   Fukuda, Takahiro ^a   Tokumaru, Aya M ^d   Hashimoto, Masaya ^a   Suzuki, Masahiko ^a   Ishiwata, Kiichi ^e   Ishii, Kenji ^e   Mochio, Soichiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c Saiseikai Kurihashi Hospital   (Japan)

^d Tokyo Metropolitan Medical Center of Gerontology   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Cerebral amyloid angiopathy; Hemodialysis; PET; Sensory aphasia; Vasogenic edema

Indexed keywords

AMYLOID BETA PROTEIN; CREATININE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; PITTSBURGH COMPOUND B; PROTEIN; URIC ACID; BENZOTHIAZOLE DERIVATIVE; CARBON; N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BIOPSY; BRAIN DISEASE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; HEMODIALYSIS; HUMAN; HUMAN TISSUE; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; UREA NITROGEN BLOOD LEVEL; VASCULAR AMYLOIDOSIS; COMPLICATION; DIFFERENTIAL DIAGNOSIS; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PROCEDURES; SCINTISCANNING;

AGED; BENZOTHIAZOLES; CARBON RADIOISOTOPES; CEREBRAL AMYLOID ANGIOPATHY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 84906835882     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1731     Document Type: Article

References (10)

1. Gray F, Dubas F, Roullet E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 18: 54-59, 1985.
2. Eng JA, Frosh MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55: 250-256, 2004.
3. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56: 537-539, 2001.
4. Kinnecom C, Lev MH, Wendell L, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology 68: 1411-1416, 2007.
5. Haacke EM, DelProposto ZS, Chaturvedi S, et al. Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. Am J Neuroradiol 28: 316-317, 2007.
6. Schrag M, McAuley G, Pomakian J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol 119: 291-302, 2010.
7. Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 62: 229-234, 2007.
8. Ly JV, Donnan GA, Villemagne VL, et al.11C PiB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology 74: 487-493, 2010.
9. Lummel N, Lutz J, Bruckmann H, Linn J. The value of magnetic resonance imaging for the detection of the bleeding source in nontraumatic intracerebral haemorrhages: a comparison with conventional digital subtraction angiography. Neuroradiology 54: 673-680, 2012.
10. Oh U, Gupta R, Krakauer JW, Khandji AG, Chin SS, Elkind MSV. Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 62: 494-497, 2004.